Diagnosis and treatment of pulmonary embolism during the COVID-19 pandemic: A position paper from the national pert consortium
Date
2020Author
Rosovsky, Rachel P.
Grodzin, Charles
Channick, Richard
Davis, George A.
Giri, Jay S.
Horowitz, James
Kabrhe, Christopher
Lookstein, Robert
Merli, Geno
Morris, Timothy A.
Rivera-Lebron, Belinda
Tapson, Victor
Todoran, Thomas M.
Weinberg, Aaron S.
Rosenfield, Kenneth
Metadata
Show full item record
Imagenes y Videos
Abstract
The co-existence of COVID-19 and PE, two life threatening illnesses, in the same patient
presents a unique challenge. Recent guidelines have delineated how best to diagnose and
manage patients with PE. However, the unique aspects of this virus confound both the
diagnosis and treatment of PE, and thus require modification of established algorithms.1-
6
Important considerations include adjustment of diagnostic modalities, incorporation of the
pro-thrombotic contribution of COVID-19, management of two critical cardio-respiratory illnesses
in the same patient, and protecting patients and health care workers while providing optimal
care. The benefits of a team-based approach for decision-making and coordination of care,
such as that offered by pulmonary embolism response teams (PERT), has become more
evident in this crisis. The importance of careful followup care also is underscored for patients
with these two diseases with long-term effects. This position paper from the PERT Consortium
specifically addresses issues related to the diagnosis and management of PE in the COVID-19
patient.
Palabras clave
COVID-19; Pulmonary embolism; Venous thromboembolism; Pulmonary embolism response team; Systemic thrombolysis; Catheter- directed thr Journal Pre-proof ombolysis; Prevention; Follow-upLink to resource
https://doi.org/10.1016/j.chest.2020.08.2064Collections
Estadísticas Google Analytics
Comments
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.